WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
WX was delisted on the 10th of December, 2015.
132 hedge funds and large institutions have $1.63B invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2013 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 34 increasing their positions, 58 reducing their positions, and 8 closing their positions.
2,556% more call options, than puts
Call options by funds: $425K | Put options by funds: $16K
263% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 8
200% more funds holding in top 10
Funds holding in top 10: 2 → 6 (+4)
29% more capital invested
Capital invested by funds: $1.26B → $1.63B (+$370M)
17% more funds holding
Funds holding: 113 → 132 (+19)
41% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 58
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
+$23.7M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$17.8M |
| 3 |
CCAM
Coupland Cardiff Asset Management
London,
United Kingdom
|
+$11.5M |
| 4 |
SR
Sloane Robinson
London,
United Kingdom
|
+$7.18M |
| 5 |
Ninety One (UK)
London,
United Kingdom
|
+$7.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BTP
Bloom Tree Partners
New York
|
-$10.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.62M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
-$8.54M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$8.02M |
| 5 |
BG
BlackRock Group
London,
United Kingdom
|
-$7.74M |
WX Hedge Fund Activity: Q3 2013 in Review
132 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q3 2013, worth a combined $1.63B — up 29% from $1.26B a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new WX positions and 8 closed out — a net gain of 21 holders — while 34 added to existing stakes and 58 trimmed.
The largest buyer was Consonance Capital Management, opening a new position worth an estimated $23.7M. The largest seller was Bloom Tree Partners, exiting entirely with an estimated $10.9M sold.
- 132 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q3 2013, up from 113 in Q2 2013.
- Funds reported $1.63B of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q3 2013, up 29% quarter-over-quarter.
- 29 funds opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q3 2013 and 8 closed out, a net change of +21 holders.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q3 2013 was Consonance Capital Management, an estimated $23.7M added.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q3 2013 was Bloom Tree Partners, an estimated $10.9M sold.
Based on aggregated 13F filings for Q3 2013.